NCT00237250View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

PHASE3CompletedINTERVENTIONAL

Enrollment

171

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Prediabetic State

Interventions

DRUG

vildagliptin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY